Breaking News

  • 1 day ago

  • Vaibhavi M.

Sygnature Discovery Partners with DaltonTx to Accelerate AI-Driven Medicinal Chemistry Decision-Making
Breaking News

More News

Kura Oncology and Kyowa Kirin Report Phase 1/2 KOMET-007 Long-Term Survival Data Supporting Frontline AML Registration

Kura Oncology and Kyowa Kirin Report Phase 1/2 KOMET-007 Long-Term Sur...

Vaibhavi M.

60 Degrees Pharmaceuticals Signs FSU Patent License for Australian Chestnut Extract Supplement

60 Degrees Pharmaceuticals Signs FSU Patent License for Australian Che...

Vaibhavi M.

FDA Authorizes Generic Nitenpyram Tablets for New World Screwworm Treatment in Dogs and Cats

FDA Authorizes Generic Nitenpyram Tablets for New World Screwworm Trea...

Vaibhavi M.

Adial Pharmaceuticals Acquires Azora Therapeutics in Deal Worth Up to $64 Million

Adial Pharmaceuticals Acquires Azora Therapeutics in Deal Worth Up to ...

Vaibhavi M.

Ad
Advertisement

Interviews & Opinions

Article

From Microbiologist to Pharma Leader : Hemanth Panasa on FDA Audits, Contamination Control & Aseptic...

Hemanth Panasa delayed an FDA inspection by 9 months and got zero observations. On aseptic failures, media fills, gowning myths, and why the biggest c...

FT - Mr. Hemanth Panasa

Read More

Article
“If You Want to Be a King, First Behave Like One” Naresh Kumar Gaur on Leadership & Ownership

FT - Mr. Naresh Kumar Gaur

Article
From ‘Why Reject?’ to ‘How Release?’: Deepak Kasbi on the Cultural Shift in Pharma Quality

FT - Mr. Deepak Kasbi

Article
Five Pillars Of Leadership That Built A Pharma Veteran: Shyam Khante’s 45-Year Pharma Journey

FT - Mr. Shyam Khante

Ad
Advertisement
Ad